Park Ha Biological Technology Co., Ltd.

Park Ha Biological Technology Co., Ltd. (BYAH) has shown no cyber incidents or material red-flag 8-K filings in our 90-day monitoring window. However, absence of recent events provides limited visibility into underlying structural risks—dilution patterns, capital raise history, and leverage dynamics often emerge only with deeper historical analysis. The full $49 Report extends our observation window to 12 months, adds dilution risk scoring, contextualizes any financing activity, and flags AI-related business model risks that short windows can miss. For biotech issuers trading in lower-liquidity markets, this extended lens often reveals the factors that drive valuation volatility.